Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Noevir Holdings Co Ltd
4928Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparel and aircrafts. The company also produces and sells toiletries; market research; and provides air transportation and training services. The company sells its products through drug stores and variety stores, and dermatology and medical institutions, as well as Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Chuo, Japan. Address: 6-13-1 Minatojima-Nakamachi, Chuo, Japan, 650-8521
Analytics
WallStreetin tavoitehinta
821 062.41 JPYP/E-suhde
21.3432Osinkotuotto
4.86 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut 4928
Osinkoanalytiikka 4928
Osinkojen kasvu 5 vuoden aikana
22 %Jatkuva kasvu
3 vuottaMaksusuhde 5 vuoden keskiarvo
99 %Osinkohistoria 4928
Osakkeen arvostus 4928
Talousasiat 4928
Tuloksia | 2019 | Dynamiikka |